5-MAPDB

5-MAPDB (1-(2,3-dihydrobenzofuran-5-yl)propan-2-amine) is a psychedelic and entactogenic drug of the amphetamine class. It is a member of the benzofuran series of amphetamines, which also includes compounds like 5-APB, 6-APB, and MDMA.

Chemistry

5-MAPDB is a chemical compound that belongs to the benzofuran class of amphetamines. The full chemical name of 5-MAPDB is 1-(2,3-dihydrobenzofuran-5-yl)propan-2-amine. The structure of 5-MAPDB is closely related to that of other benzofuran amphetamines, such as 5-APB and 6-APB.

Pharmacology

The pharmacology of 5-MAPDB is not fully understood. However, it is known to act as a serotonin-norepinephrine-dopamine releasing agent (SNDRA). This means it increases the levels of these neurotransmitters in the brain by promoting their release from neurons. This can result in effects such as increased energy, euphoria, and altered perception.

Effects

The effects of 5-MAPDB can vary greatly depending on the dose, the individual's physiology, and the environment in which it's taken. Common effects reported by users include feelings of euphoria, increased energy, enhanced empathy and sociability, and altered perception of time and space. Some users also report experiencing visual and auditory hallucinations.

Legality

The legality of 5-MAPDB varies by country. In some countries, such as the United States, it is classified as a Schedule I controlled substance, making it illegal to manufacture, distribute, or possess. In other countries, it may be legal or regulated under analogue laws.

Risks

As with all psychoactive substances, there are risks associated with the use of 5-MAPDB. These can include both physical and psychological effects, such as increased heart rate and blood pressure, anxiety, and paranoia. There is also the potential for dependence and abuse.

See also

• 5-APB
• 6-APB
• MDMA
• Amphetamine
• Psychedelic drug
• Entactogen

‎ Template:Amphetamine-stub